table of content
1 Study Coverage
1.1 Migraine Drugs Product Introduction
1.2 Global Migraine Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Migraine Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Migraine Drugs Sales in Volume for the Year 2017-2028
1.3 United States Migraine Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Migraine Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Migraine Drugs Sales in Volume for the Year 2017-2028
1.4 Migraine Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Migraine Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Migraine Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Migraine Drugs Market Dynamics
1.5.1 Migraine Drugs Industry Trends
1.5.2 Migraine Drugs Market Drivers
1.5.3 Migraine Drugs Market Challenges
1.5.4 Migraine Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Migraine Drugs Market Segment by Type
2.1.1 Sumatriptan
2.1.2 Zolmitriptan
2.1.3 Rizatriptan
2.1.4 Others Drug
2.2 Global Migraine Drugs Market Size by Type
2.2.1 Global Migraine Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Migraine Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Migraine Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Migraine Drugs Market Size by Type
2.3.1 United States Migraine Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Migraine Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Migraine Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Migraine Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Household Use
3.1.4 Others
3.2 Global Migraine Drugs Market Size by Application
3.2.1 Global Migraine Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Migraine Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Migraine Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Migraine Drugs Market Size by Application
3.3.1 United States Migraine Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Migraine Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Migraine Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Migraine Drugs Competitor Landscape by Company
4.1 Global Migraine Drugs Market Size by Company
4.1.1 Top Global Migraine Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Migraine Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Migraine Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Migraine Drugs Price by Manufacturer (2017-2022)
4.2 Global Migraine Drugs Concentration Ratio (CR)
4.2.1 Migraine Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Migraine Drugs in 2021
4.2.3 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Migraine Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Migraine Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Migraine Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Migraine Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Migraine Drugs Market Size by Company
4.5.1 Top Migraine Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Migraine Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Migraine Drugs Sales by Players (2020, 2021 & 2022)
5 Global Migraine Drugs Market Size by Region
5.1 Global Migraine Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Migraine Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Migraine Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Migraine Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Migraine Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Migraine Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Migraine Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Migraine Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Migraine Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Migraine Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Migraine Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Migraine Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Migraine Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Migraine Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Migraine Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Migraine Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Migraine Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Corporation Information
7.1.2 Allergan Description and Business Overview
7.1.3 Allergan Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Allergan Migraine Drugs Products Offered
7.1.5 Allergan Recent Development
7.2 Merck
7.2.1 Merck Corporation Information
7.2.2 Merck Description and Business Overview
7.2.3 Merck Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Migraine Drugs Products Offered
7.2.5 Merck Recent Development
7.3 Pfizer
7.3.1 Pfizer Corporation Information
7.3.2 Pfizer Description and Business Overview
7.3.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Migraine Drugs Products Offered
7.3.5 Pfizer Recent Development
7.4 Teva
7.4.1 Teva Corporation Information
7.4.2 Teva Description and Business Overview
7.4.3 Teva Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Teva Migraine Drugs Products Offered
7.4.5 Teva Recent Development
7.5 Pfizer
7.5.1 Pfizer Corporation Information
7.5.2 Pfizer Description and Business Overview
7.5.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Pfizer Migraine Drugs Products Offered
7.5.5 Pfizer Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporation Information
7.6.2 Johnson & Johnson Description and Business Overview
7.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Johnson & Johnson Migraine Drugs Products Offered
7.6.5 Johnson & Johnson Recent Development
7.7 Endo International
7.7.1 Endo International Corporation Information
7.7.2 Endo International Description and Business Overview
7.7.3 Endo International Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Endo International Migraine Drugs Products Offered
7.7.5 Endo International Recent Development
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporation Information
7.8.2 GlaxoSmithKline Description and Business Overview
7.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 GlaxoSmithKline Migraine Drugs Products Offered
7.8.5 GlaxoSmithKline Recent Development
7.9 Impax
7.9.1 Impax Corporation Information
7.9.2 Impax Description and Business Overview
7.9.3 Impax Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Impax Migraine Drugs Products Offered
7.9.5 Impax Recent Development
7.10 Abbott
7.10.1 Abbott Corporation Information
7.10.2 Abbott Description and Business Overview
7.10.3 Abbott Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Abbott Migraine Drugs Products Offered
7.10.5 Abbott Recent Development
7.11 Bayer
7.11.1 Bayer Corporation Information
7.11.2 Bayer Description and Business Overview
7.11.3 Bayer Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Bayer Migraine Drugs Products Offered
7.11.5 Bayer Recent Development
7.12 Eli Lilly
7.12.1 Eli Lilly Corporation Information
7.12.2 Eli Lilly Description and Business Overview
7.12.3 Eli Lilly Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Eli Lilly Products Offered
7.12.5 Eli Lilly Recent Development
7.13 Ethypharm
7.13.1 Ethypharm Corporation Information
7.13.2 Ethypharm Description and Business Overview
7.13.3 Ethypharm Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Ethypharm Products Offered
7.13.5 Ethypharm Recent Development
7.14 Kowa Pharmaceuticals America
7.14.1 Kowa Pharmaceuticals America Corporation Information
7.14.2 Kowa Pharmaceuticals America Description and Business Overview
7.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Kowa Pharmaceuticals America Products Offered
7.14.5 Kowa Pharmaceuticals America Recent Development
7.15 Winston Pharmaceuticals
7.15.1 Winston Pharmaceuticals Corporation Information
7.15.2 Winston Pharmaceuticals Description and Business Overview
7.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Winston Pharmaceuticals Products Offered
7.15.5 Winston Pharmaceuticals Recent Development
7.16 AstraZeneca
7.16.1 AstraZeneca Corporation Information
7.16.2 AstraZeneca Description and Business Overview
7.16.3 AstraZeneca Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 AstraZeneca Products Offered
7.16.5 AstraZeneca Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Migraine Drugs Industry Chain Analysis
8.2 Migraine Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Migraine Drugs Distributors
8.3 Migraine Drugs Production Mode & Process
8.4 Migraine Drugs Sales and Marketing
8.4.1 Migraine Drugs Sales Channels
8.4.2 Migraine Drugs Distributors
8.5 Migraine Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
